GCG and type 2 diabetes mellitus: There is also increasing evidence from animal models to support a potential role for GLP-1 in neuroprotection, and the increased risk of developing neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease in patients with T2DM suggests that there may be shared underlying mechanisms in these conditions [39].